Get started
Clene Inc.Clene Inc.Clene Inc.

Clene Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

CLNN chart


Full chart

CLNN upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪27.36 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.87 USD
Net income (FY)
‪−39.40 M‬ USD
Revenue (FY)
‪342.00 K‬ USD
Shares float
‪5.68 M‬
Beta (1Y)
1.07

Employees


Employees (FY)
76
Change (1Y)
−9 −10.59%
Revenue / Employee (1Y)
‪4.50 K‬ USD
Net income / Employee (1Y)
‪−518.42 K‬ USD

About Clene Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Robert Dee Etherington
Website
clene.com
Headquarters
Salt Lake City
Founded
2013
FIGI
BBG00X3GTK66
Clene, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It offers a nanotechnology drug platform for the development of a new class of orally administered neurotherapeutic drugs. The company was founded in 2013 and is headquartered in Salt Lake City, UT.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

CLNN news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as CLNN.

Frequently Asked Questions


The current price of CLNN is 3.05 USD — it has decreased by −5.05% in the past 24 hours. Watch Clene Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Clene Inc. stocks are traded under the ticker CLNN.
CLNN stock has fallen by −0.99% compared to the previous week, the month change is a −15.21% fall, over the last year Clene Inc. has showed a −54.48% decrease.
We've gathered analysts' opinions on Clene Inc. future price: according to them, CLNN price has a max estimate of 31.00 USD and a min estimate of 20.00 USD. Watch CLNN chart and read a more detailed Clene Inc. stock forecast: see what analysts think of Clene Inc. and suggest that you do with its stocks.
CLNN reached its all-time high on Jul 13, 2021 with the price of 356.40 USD, and its all-time low was 2.57 USD and was reached on Apr 1, 2025. View more price dynamics on CLNN chart.
See other stocks reaching their highest and lowest prices.
CLNN stock is 5.67% volatile and has beta coefficient of 1.07. Track Clene Inc. stock price on the chart and check out the list of the most volatile stocks — is Clene Inc. there?
Today Clene Inc. has the market capitalization of ‪27.36 M‬, it has decreased by −0.99% over the last week.
Yes, you can track Clene Inc. financials in yearly and quarterly reports right on TradingView.
Clene Inc. is going to release the next earnings report on May 13, 2025. Keep track of upcoming events with our Earnings Calendar.
CLNN earnings for the last quarter are −1.59 USD per share, whereas the estimation was −0.97 USD resulting in a −64.40% surprise. The estimated earnings for the next quarter are −0.95 USD per share. See more details about Clene Inc. earnings.
Clene Inc. revenue for the last quarter amounts to ‪91.00 K‬ USD, despite the estimated figure of ‪138.33 K‬ USD. In the next quarter, revenue is expected to reach ‪75.67 K‬ USD.
CLNN net income for the last quarter is ‪−13.55 M‬ USD, while the quarter before that showed ‪−7.99 M‬ USD of net income which accounts for −69.66% change. Track more Clene Inc. financial stats to get the full picture.
No, CLNN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 25, 2025, the company has 76 employees. See our rating of the largest employees — is Clene Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Clene Inc. EBITDA is ‪−31.45 M‬ USD, and current EBITDA margin is ‪−9.20 K‬%. See more stats in Clene Inc. financial statements.
Like other stocks, CLNN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Clene Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Clene Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Clene Inc. stock shows the sell signal. See more of Clene Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.